• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Smallholders unable to afford essential farm inputs, expert says
  • Farmers say high costs drive up catfish prices
  • NEWSAN calls for urgent repairs to sewage systems
  • Rising feed costs push farmers out of business
  • Naira slips to ₦1,379.99/$ as interbank FX turnover tops $500m
  • FAAC shares ₦2.44trn October revenue as statutory, VAT receipts decline
  • State trains veterinarians to expand rural services
  • UniCal Alumni turn to agribusiness to tackle graduate unemployment
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Smallholders unable to afford essential farm inputs, expert says

    November 19, 2026

    Farmers say high costs drive up catfish prices

    November 19, 2026

    Rising feed costs push farmers out of business

    November 19, 2026

    State trains veterinarians to expand rural services

    November 19, 2026

    UniCal Alumni turn to agribusiness to tackle graduate unemployment

    November 19, 2026
  • Sci & Tech

    Sultan inaugurates 500-seat ICT centre at Saki nursing college, backs health technology expansion

    November 19, 2026

    Linking payment systems key to Africa’s trade integration, officials say

    November 19, 2026

    CJID announces 2026 media, development conference

    November 18, 2026

    GOVMAIL adoption grows across Nigeria’s public sector

    November 17, 2026

    CADEF: Low public trust threatens Nigeria’s energy transition

    November 14, 2026
  • Health

    Foundation, ACF urge investment in boys’ development

    November 19, 2026

    Nigeria’s home care framework launched to support vulnerable people

    November 19, 2026

    WHO calls for coordinated action to curb antimicrobial resistance

    November 19, 2026

    Men should seek early medical care, NMA chief says

    November 19, 2026

    First lady calls for UN recognition of men’s day

    November 19, 2026
  • Environment

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026

    Nigeria targets open defecation free status by 2030

    November 19, 2026

    Erosion puts Cross River transmission line at risk

    November 19, 2026

    Partnership targets open defecation in 8 states

    November 18, 2026

    Air Peace adds more daily flights between Lagos, Abuja

    November 18, 2026
  • Hausa News

    Foundation unveils public sector reform playbook

    November 12, 2026

    Tinubu asks Reps to approve N10.79tn external borrowing for 2026 budget

    November 11, 2026

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Smallholders unable to afford essential farm inputs, expert says

    November 19, 2026

    Farmers say high costs drive up catfish prices

    November 19, 2026

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Smallholders unable to afford essential farm inputs, expert says

    November 19, 2026

    Farmers say high costs drive up catfish prices

    November 19, 2026

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»General News»COVID-19: AstraZeneca seeks FDA approval for antibody treatment
General News

COVID-19: AstraZeneca seeks FDA approval for antibody treatment

Abdallah el-KurebeBy Abdallah el-KurebeOctober 6, 2021No Comments2 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

AstraZeneca has asked the Food and Drug Administration (FDA) to approve its COVID-19 antibody treatment that would act as a long-acting drug mainly for those with compromised immune systems.

The drug-maker, which was among the first to create a COVID-19 vaccine, said its antibody treatment, AZD7442, is a first of its kind therapy that utilizes long-acting antibody protection.

“First and foremost we want to protect those vulnerable populations that haven’t been adequately protected by the vaccine.

“But ultimately it will be up to health authorities to work out who they choose to immunize,” said Menelas Pangaloa, AstraZeneca’s head of Research and Development.

According to Pangaloa, the antibody treatment is made for boosting a person’s immunity for up to a year.

He said the current antibody drugs only offer just a month or two of protection.

The FDA has already authorized three additional antibody drugs.

“Two of those drugs can be distributed after a person has been exposed to COVID-19 and will help prevent symptoms.

“AstraZeneca’s drug on the other hand would only be given as a preventive measure in addition to a vaccine.

“On the topic of vaccinations, the FDA has already said that any antibody remedies are not a reason to avoid getting vaccinated.

“That is because they offer the best level of protection, especially for the long-term.”

According to studies conducted by AstraZeneca, their antibody treatment reduced the chance of developing Covid-19 related symptoms by 77 per cent.

More than three-quarters of the participants in this study were immunocompromised already.

Pangalos added that the drug will provide an additional option to help protect against COVID-19 alongside vaccines.

AstraZeneca also intends to ask for authorization of their treatment in Europe.

tca/dpa

antibody treatment AstraZeneca COVIUD-19 FDA
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Abdallah el-Kurebe
  • Website
  • Facebook
  • Twitter
  • LinkedIn

Related Posts

Naira slips to ₦1,379.99/$ as interbank FX turnover tops $500m

November 19, 2026

FAAC shares ₦2.44trn October revenue as statutory, VAT receipts decline

November 19, 2026

Foundation, ACF urge investment in boys’ development

November 19, 2026

Leave A Reply Cancel Reply

Smallholders unable to afford essential farm inputs, expert says

November 19, 2026

Farmers say high costs drive up catfish prices

November 19, 2026

NEWSAN calls for urgent repairs to sewage systems

November 19, 2026

Rising feed costs push farmers out of business

November 19, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.